Epstein Secrets

L 2 DRAFT - Jeffery Epstein EFTA00617641 DNA sequencing, estimates a $20 billion addressable market for sequencing technology and applications. McKinsey & Company estimates that genomics will have an economic impact of up to $1.6 trillion on global GDP by 2025. • Smart sensors and remote-monitoring technolog

tries, including emerging countries that have legal and regulatory environments that are significantly different from those of the United States or Western Europe. Specifically, investments in such companies may be subject to (i) economic, market, political and local risks related to the governmental systems i

Member of the Practice Committee Co-Founder Kibar Holding AS HSBC Asia Pacific Free the Children Swiss Reinsurance Company Ltd Projeto Cies McKinsey & Company Hanwha SolarOne Samsung Engineering Co. Ltd Hanwha Biologics, Hanwha Chemical Corporation Daesung Group Bridgewater Associates LP Mitsubishi C

), New York Chief Operating Officer Vice-President, Beer and Better World Group Head, Human Resources and Communications Vice-President, Sales, Western Europe, Africa and Middle East President, Chairman of the Board and Chief Executive Officer Senior Vice-President, Global Initiatives, Strategy and Bus

pany oversight efforts on the firm’s healthcare information technology portfolio. Prior to joining Francisco Partners, Eric worked for three years at McKinsey & Company as a Senior Business Analyst in their Corporate Finance Practice. Eric received his dual B.A. in Mathematical Methods in the Social Sciences and Econ

s & Infrastructure. Investments will be predominantly in the U.S., but could include a small number of investments in other parts of the world (e.g., Western Europe or Canada). The focus within each sector will be the following: Biopharmaceuticals: As in NLV-I and NLV-II, biopharmaceutical investments will be th